Lorenz Thurner

2.0k total citations
63 papers, 730 citations indexed

About

Lorenz Thurner is a scholar working on Pathology and Forensic Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Lorenz Thurner has authored 63 papers receiving a total of 730 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pathology and Forensic Medicine, 18 papers in Oncology and 15 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Lorenz Thurner's work include Lymphoma Diagnosis and Treatment (27 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and Chronic Lymphocytic Leukemia Research (10 papers). Lorenz Thurner is often cited by papers focused on Lymphoma Diagnosis and Treatment (27 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and Chronic Lymphocytic Leukemia Research (10 papers). Lorenz Thurner collaborates with scholars based in Germany, France and United States. Lorenz Thurner's co-authors include Moritz Bewarder, Dominic Kaddu‐Mulindwa, Michael Pfreundschuh, Stephan Stilgenbauer, Klaus‐Dieter Preuss, Natalie Fadle, Sylvia Hartmann, Evi Regitz, Konstantinos Christofyllakis and Hans‐Jochen Heinze and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Lorenz Thurner

56 papers receiving 724 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lorenz Thurner Germany	16	235	233	215	157	126	63	730
Itsuko Nakamichi Japan	12	113 0.5×	303 1.3×	266 1.2×	151 1.0×	54 0.4×	28	673
Kathleen Quigley United States	16	148 0.6×	379 1.6×	195 0.9×	85 0.5×	249 2.0×	22	976
Ioanna Sakellari Greece	20	149 0.6×	466 2.0×	421 2.0×	140 0.9×	466 3.7×	91	1.5k
Hideo Sakuma Japan	15	197 0.8×	96 0.4×	89 0.4×	146 0.9×	82 0.7×	61	655
Jeremy A. Goss United States	15	314 1.3×	125 0.5×	374 1.7×	114 0.7×	73 0.6×	33	956
Eliana Miranda Brazil	16	103 0.4×	100 0.4×	188 0.9×	190 1.2×	193 1.5×	70	1.1k
Magali Le Garff‐Tavernier France	15	312 1.3×	435 1.9×	204 0.9×	130 0.8×	511 4.1×	62	1.3k
Shin Kwang Khang South Korea	20	240 1.0×	155 0.7×	211 1.0×	146 0.9×	32 0.3×	63	1.0k
Eileen Boye United States	17	254 1.1×	132 0.6×	305 1.4×	429 2.7×	40 0.3×	21	1.2k
Sanda Alexandrescu United States	19	374 1.6×	87 0.4×	117 0.5×	320 2.0×	82 0.7×	65	1.2k

Countries citing papers authored by Lorenz Thurner

Since Specialization

Citations

This map shows the geographic impact of Lorenz Thurner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorenz Thurner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorenz Thurner more than expected).

Fields of papers citing papers by Lorenz Thurner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorenz Thurner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorenz Thurner. The network helps show where Lorenz Thurner may publish in the future.

Co-authorship network of co-authors of Lorenz Thurner

This figure shows the co-authorship network connecting the top 25 collaborators of Lorenz Thurner. A scholar is included among the top collaborators of Lorenz Thurner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorenz Thurner. Lorenz Thurner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schneitler, Sophie, Sabine Zange, Maximilian Linxweiler, et al.. (2025). Clinical characteristics of and diagnostic approaches to human Francisella tularensis infection: a retrospective, monocentric case study from Germany. Ticks and Tick-borne Diseases. 16(4). 102492–102492. 1 indexed citations

Nigdelis, Meletios P., Moritz Bewarder, Joerg Thomas Bittenbring, et al.. (2025). Secondary hemophagocytic lymphohistiocytosis associated with adjuvant pembrolizumab therapy in a young patient with triple-negative breast cancer: a case report with literature review. Archives of Gynecology and Obstetrics. 312(5). 1813–1820. 1 indexed citations

Neumann, Frank, Konstantinos Christofyllakis, Igor Age Kos, et al.. (2024). Hyper-N-glycosylated SEL1L3 as auto-antigenic B-cell receptor target of primary vitreoretinal lymphomas. Scientific Reports. 14(1). 9571–9571. 1 indexed citations

Fadle, Natalie, Evi Regitz, Igor Age Kos, et al.. (2024). Autoantibody mediated deficiency of IL-36-receptor antagonist in a subset of patients with psoriasis and psoriatic arthritis. Immunology Letters. 270. 106926–106926. 2 indexed citations

Bewarder, Moritz, Dominic Kaddu‐Mulindwa, Igor Age Kos, et al.. (2023). Impact of vincristine dose reduction on outcomes of patients with aggressive B-cell lymphoma treated with (R)-CHOP. Haematologica. 108(10). 2844–2849. 2 indexed citations

Poos, Alexandra M., Marc S. Raab, Hartmut Goldschmidt, et al.. (2023). Comparison of IGLV2‐14 light chain sequences of patients with AL amyloidosis or multiple myeloma. FEBS Journal. 290(17). 4256–4267. 2 indexed citations

Christofyllakis, Konstantinos, Frank Neumann, Moritz Bewarder, et al.. (2023). Vitamin D Enhances Immune Effector Pathways of NK Cells Thus Providing a Mechanistic Explanation for the Increased Effectiveness of Therapeutic Monoclonal Antibodies. Nutrients. 15(16). 3498–3498. 5 indexed citations

Jung, Philipp, Alexander Halfmann, Matthias Schröder, et al.. (2023). A multi-pronged approach to improve blood culture diagnostics in different clinical departments: a single-centre experience. Infection. 52(1). 183–195.

Kos, Igor Age, Joerg Thomas Bittenbring, Manfred Ahlgrimm, et al.. (2022). Adaptive humoral immune response and cellular immune status in cancer patients and patients under immunosuppression vaccinated against SARS-CoV-2. Expert Review of Vaccines. 21(11). 1683–1689. 1 indexed citations

10.

Kaddu‐Mulindwa, Dominic, Philipp Gödel, Nadine Kutsch, et al.. (2022). Salvage High-dose Melphalan With Autologous Stem cell Transplantation as Bridge to Consolidation Therapy for Chemoresistant Aggressive B-cell Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 22(7). e498–e506. 1 indexed citations

11.

Kaddu‐Mulindwa, Dominic, Lorenz Thurner, Konstantinos Christofyllakis, Moritz Bewarder, & Igor Age Kos. (2022). Management of Extranodal Marginal Zone Lymphoma: Present and Upcoming Perspectives. Cancers. 14(12). 3019–3019. 7 indexed citations

12.

Bewarder, Moritz, Stephan Stilgenbauer, Lorenz Thurner, & Dominic Kaddu‐Mulindwa. (2021). Current Treatment Options in CLL. Cancers. 13(10). 2468–2468. 30 indexed citations

13.

Kaddu‐Mulindwa, Dominic, Bettina Altmann, Gerhard Held, et al.. (2021). FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trials. European Journal of Nuclear Medicine and Molecular Imaging. 48(11). 3550–3559. 20 indexed citations

14.

Kos, Igor Age, Lorenz Thurner, Joerg Thomas Bittenbring, Konstantinos Christofyllakis, & Dominic Kaddu‐Mulindwa. (2021). Advances in Lymphoma Molecular Diagnostics. Diagnostics. 11(12). 2174–2174. 4 indexed citations

15.

Thurner, Lorenz, Natalie Fadle, Joerg Thomas Bittenbring, et al.. (2021). LRPAP1 autoantibodies in mantle cell lymphoma are associated with superior outcome. Blood. 137(23). 3251–3258. 7 indexed citations

16.

Kaddu‐Mulindwa, Dominic, Christian Berdel, Stephan Stilgenbauer, et al.. (2021). Significant reduced loss of bone mineral density after four vs. six cycles of R-CHOP: an analysis of the FLYER-trial. Leukemia & lymphoma. 63(2). 326–334. 2 indexed citations

17.

Kaddu‐Mulindwa, Dominic, Jürgen Rissland, Sigrun Smola, et al.. (2021). IgG seroprevalence of COVID‐19 among people living with HIV or at high risk of HIV in south‐west Germany: A seroprevalence study. HIV Medicine. 23(5). 564–569. 3 indexed citations

18.

Bewarder, Moritz, Stephan Stilgenbauer, Konstantinos Christofyllakis, et al.. (2020). Integration of the B-Cell Receptor Antigen Neurabin-I/SAMD14 Into an Antibody Format as New Therapeutic Approach for the Treatment of Primary CNS Lymphoma. Frontiers in Oncology. 10. 580364–580364. 5 indexed citations

19.

Johnson, Jennifer, Qingyun Tian, Jinlong Jian, et al.. (2016). Serum progranulin levels in Hispanic rheumatoid arthritis patients treated with TNF antagonists: a prospective, observational study. Clinical Rheumatology. 36(3). 507–516. 12 indexed citations

20.

Thurner, Lorenz, Natalie Fadle, Philipp Klemm, et al.. (2014). Proinflammatory Progranulin Antibodies in Inflammatory Bowel Diseases. Digestive Diseases and Sciences. 59(8). 1733–1742. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact